ArticleMolecular cancer therapeutics2020

Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients.

Eugene S Bah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.